tiprankstipranks
Maze Therapeutics, Inc. (MAZE)
NASDAQ:MAZE
US Market
MAZE
Maze Therapeutics, Inc.
RESEARCH TOOLSreports

Maze Therapeutics, Inc. (MAZE) Financial Statements

Compare
71 Followers

Maze Therapeutics, Inc. Financial Overview

Maze Therapeutics, Inc.'s market cap is currently $1.58B. The company's EPS TTM is $; its P/E ratio is -13.58; Maze Therapeutics, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Dec 23Dec 22
Income Statement
Total Revenue$ 0.00$ 167.50M$ 0.00$ 0.00
Gross Profit$ 0.00$ 167.50M$ 0.00$ 0.00
Operating Income$ -142.90M$ 57.59M$ -98.55M$ -111.03M
EBITDA$ -142.90M$ 60.88M$ -94.46M$ -107.21M
Net Income$ -131.12M$ 52.23M$ -100.42M$ -114.94M
Balance Sheet
Cash & Short-Term Investments$ 341.92M$ 196.81M$ 29.16M$ 99.92M
Total Assets$ 397.13M$ 240.54M$ 71.50M$ 149.96M
Total Debt$ 23.31M$ 26.63M$ 49.62M$ 32.05M
Net Debt$ -165.94M$ -170.18M$ 20.46M$ -67.86M
Total Liabilities$ 42.16M$ 43.64M$ 61.45M$ 48.51M
Stockholders' Equity$ 354.97M$ 196.90M$ 10.05M$ 101.44M
Cash Flow
Free Cash Flow$ -112.73M$ 74.81M$ -87.27M$ -101.17M
Operating Cash Flow$ -111.94M$ 75.95M$ -86.83M$ -99.20M
Investing Cash Flow$ -170.96M$ -1.15M$ -441.00K$ -3.17M
Financing Cash Flow$ 275.34M$ 92.85M$ 16.39M$ 1.73M
Currency in USD

Maze Therapeutics, Inc. Earnings and Revenue History

Income Statement >

Maze Therapeutics, Inc. Debt to Assets

Balance Sheet >

Maze Therapeutics, Inc. Cash Flow

Cash Flow >

Maze Therapeutics, Inc. Forecast EPS vs Actual EPS

Earnings >